[Remote] Medical Director, Endocrinology at Corcept Therapeutics

Remote

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Proven experience designing and executing real-world data generation and post-marketing studies in compliance with FDA standards
Familiarity with real-world data sources (claims, EHR, registries, digital health data), data linkage and data-governance, and analytical methodologies
Experience in developing and implementing data generation strategies
Experience managing CROs to ensure study quality, timeliness, and compliance
Proven ability to build and maintain relationships with key opinion leaders (KOLs), investigators, academic networks and external research organizations
Ability to think strategically and demonstrated troubleshooting and problem-solving skills
Exceptional project management and organizational skills
Excellent interpersonal and communication skills
Demonstrated ability to collaborate with cross-functional teams to achieve common goals and drive project success
Excellent oral presentation skills

Responsibilities

Collaborate cross-functionally with Clinical Development, Medical Affairs, Pharmacovigilance, Market Access, and Commercial teams to define late-phase data needs
Develop and implement data generation strategies to support evidence-based decision-making
Translate data generation strategy into clinical trial outlines and protocols
Lead the Registry and support IIS, including planning, execution, and management
Medical Monitor for Real-World data generation, and partner with an external CRO to ensure studies are executed in compliance with GCP, ICH, and local regulatory requirements
Collaborate with investigators and study sites to support study execution and data collection
Analyze and interpret study results in the context of clinical practice and real-world patient populations
Develop and implement KOL engagement plans to support medical and scientific initiatives
Facilitate scientific discussions and collaborations with KOLs to advance knowledge and advocacy for Corcept’s products and disease areas
Support data dissemination through peer-reviewed publications, congress presentations, and medical education initiatives
Contribute to the development and execution of Medical Affairs strategies and plans
Collaborate with cross-functional teams to ensure alignment and successful implementation of strategies
Maintain the highest standards of scientific, clinical, and technical expertise in relevant therapeutic areas
Travel required, up to 20%

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters

1998Year Founded

$39.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.

Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.

Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.

Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.

Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.

Advancements in drug delivery systems could enhance Corcept's product efficacy.

The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free